Enhancing the tolerability of tacrine with propantheline

Am J Psychiatry. 1999 Jan;156(1):156. doi: 10.1176/ajp.156.1.156.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Alzheimer Disease / drug therapy*
  • Cholinergic Antagonists / administration & dosage
  • Cholinergic Antagonists / therapeutic use*
  • Cholinesterase Inhibitors / administration & dosage
  • Cholinesterase Inhibitors / adverse effects*
  • Cholinesterase Inhibitors / therapeutic use
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Gastrointestinal Diseases / chemically induced*
  • Gastrointestinal Diseases / prevention & control*
  • Humans
  • Male
  • Middle Aged
  • Propantheline / administration & dosage
  • Propantheline / therapeutic use*
  • Tacrine / administration & dosage
  • Tacrine / adverse effects*
  • Tacrine / therapeutic use

Substances

  • Cholinergic Antagonists
  • Cholinesterase Inhibitors
  • Propantheline
  • Tacrine